FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095500525> ?p ?o ?g. }

• W2095500525 abstract "Abstract Human T-lymphotropic virus type 1 (HTLV-1) infection is linked to a spectrum of diverse diseases, including adult T-cell leukemia/lymphoma (ATLL) and the chronic neuromyelopathy tropical spastic paraparesis or HTLV-1 associated myelopathy (TSP/HAM). ATLL is a neoplasm of mature CD4 + T-cell origin known to be resistant to standard anti-cancer therapies. Based on ATLL research performed in our laboratory as well as other reports, we discuss diagnostic, predictive, and pharmacological biomarkers for companion diagnostics, which are vital factors for personalized oncology. From the viewpoint of resistance to apoptosis, the FAS ligand/FAS system, TRAIL/TRAIL receptor system, and survivin are promising targets for cancer therapy. The tumor suppressor genes p16 INK4a , p14 ARF , and p53 are well known predictive and pharmacological biomarkers for various cancers as well as for ATLL. We have found that the plasma miRNAs miR-155 and miR-126 have importance as novel biomarkers to evaluate disease progression and prognosis in ATLL patients. Furthermore, ATLL is considered an appropriate target disease for epigenetic therapy. Although several molecular diagnostic methods for cancer have been approved over the past decade, only a small number of predictive biomarkers have been shown to have clinical value. In a review of our ATLL research findings, we have noticed the same trend in our search for an improved biomarker, and thus the discovery of a highly precise biomarker is one of the keys for the development of superior companion diagnostics." @default.
• W2095500525 created "2016-06-24" @default.
• W2095500525 creator A5020500592 @default.
• W2095500525 creator A5054251126 @default.
• W2095500525 date "2013-07-01" @default.
• W2095500525 modified "2023-09-27" @default.
• W2095500525 title "Use of diagnostic and therapeutic biomarkers in personalized oncology based on adult T-cell leukemia/lymphoma research" @default.
• W2095500525 cites W1519245680 @default.
• W2095500525 cites W1534015759 @default.
• W2095500525 cites W1648301895 @default.
• W2095500525 cites W1895238990 @default.
• W2095500525 cites W1967007963 @default.
• W2095500525 cites W1969187681 @default.
• W2095500525 cites W1970000478 @default.
• W2095500525 cites W1973788312 @default.
• W2095500525 cites W1975336660 @default.
• W2095500525 cites W1975515453 @default.
• W2095500525 cites W1976642544 @default.
• W2095500525 cites W1977836335 @default.
• W2095500525 cites W1980878904 @default.
• W2095500525 cites W1981585007 @default.
• W2095500525 cites W1984948591 @default.
• W2095500525 cites W1987506447 @default.
• W2095500525 cites W1992989336 @default.
• W2095500525 cites W1994323817 @default.
• W2095500525 cites W1994852323 @default.
• W2095500525 cites W1995338848 @default.
• W2095500525 cites W1998017001 @default.
• W2095500525 cites W2006917576 @default.
• W2095500525 cites W2008033547 @default.
• W2095500525 cites W2015183287 @default.
• W2095500525 cites W2019276845 @default.
• W2095500525 cites W2020843710 @default.
• W2095500525 cites W2029868343 @default.
• W2095500525 cites W2033102369 @default.
• W2095500525 cites W2034042949 @default.
• W2095500525 cites W2035188342 @default.
• W2095500525 cites W2047972729 @default.
• W2095500525 cites W2054066786 @default.
• W2095500525 cites W2062086937 @default.
• W2095500525 cites W2062290101 @default.
• W2095500525 cites W2065891752 @default.
• W2095500525 cites W2071794490 @default.
• W2095500525 cites W2074947315 @default.
• W2095500525 cites W2075230059 @default.
• W2095500525 cites W2079479637 @default.
• W2095500525 cites W2082449242 @default.
• W2095500525 cites W2089225780 @default.
• W2095500525 cites W2090006731 @default.
• W2095500525 cites W2091367061 @default.
• W2095500525 cites W2095916340 @default.
• W2095500525 cites W2097799776 @default.
• W2095500525 cites W2097933346 @default.
• W2095500525 cites W2098994085 @default.
• W2095500525 cites W2099780734 @default.
• W2095500525 cites W2099803844 @default.
• W2095500525 cites W2099893634 @default.
• W2095500525 cites W2100494757 @default.
• W2095500525 cites W2100543217 @default.
• W2095500525 cites W2115093090 @default.
• W2095500525 cites W2115225962 @default.
• W2095500525 cites W2119312052 @default.
• W2095500525 cites W2126701902 @default.
• W2095500525 cites W2128077526 @default.
• W2095500525 cites W2128542677 @default.
• W2095500525 cites W2131732631 @default.
• W2095500525 cites W2132888849 @default.
• W2095500525 cites W2132931677 @default.
• W2095500525 cites W2135314242 @default.
• W2095500525 cites W2137623566 @default.
• W2095500525 cites W2138178802 @default.
• W2095500525 cites W2151124060 @default.
• W2095500525 cites W2151922790 @default.
• W2095500525 cites W2153547341 @default.
• W2095500525 cites W2158377087 @default.
• W2095500525 cites W2164052369 @default.
• W2095500525 doi "https://doi.org/10.1016/j.pmu.2013.05.001" @default.
• W2095500525 hasPublicationYear "2013" @default.
• W2095500525 type Work @default.
• W2095500525 sameAs 2095500525 @default.
• W2095500525 citedByCount "0" @default.
• W2095500525 crossrefType "journal-article" @default.
• W2095500525 hasAuthorship W2095500525A5020500592 @default.
• W2095500525 hasAuthorship W2095500525A5054251126 @default.
• W2095500525 hasConcept C118552586 @default.
• W2095500525 hasConcept C121608353 @default.
• W2095500525 hasConcept C126322002 @default.
• W2095500525 hasConcept C143998085 @default.
• W2095500525 hasConcept C203014093 @default.
• W2095500525 hasConcept C2776392238 @default.
• W2095500525 hasConcept C2777604421 @default.
• W2095500525 hasConcept C2778461978 @default.
• W2095500525 hasConcept C2779134260 @default.
• W2095500525 hasConcept C2779338263 @default.
• W2095500525 hasConcept C2780775167 @default.
• W2095500525 hasConcept C2781197716 @default.
• W2095500525 hasConcept C502942594 @default.
• W2095500525 hasConcept C55493867 @default.
• W2095500525 hasConcept C60644358 @default.
• W2095500525 hasConcept C71924100 @default.

• next